Drugs · acquisition-cost intelligence
4% Lidocaine Maximum Strength Pain Relief
4% Lidocaine· ingredient lidocaineAmides· LIDOCAINE .04 g/1; LIDOCAINE .04 g/100g; LIDOCAINE .04 g/g; LIDOCAINE 11 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$1.10
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other lidocaine products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Burn Relief | $0.02792 | −$1.08 |
| ALCEMISTE | $0.05101 | −$1.05 |
| Lidocaine Viscous | $0.07984 | −$1.02 |
| Lidocaine | $0.09024 | −$1.01 |
| lidocaine | $0.15755 | −$0.94650 |
| Cadira Compliant Blood Stat | $0.21848 | −$0.88550 |
| LIDOCAINE HCl | $0.24343 | −$0.86060 |
| Lidocaine | $0.35160 | −$0.75240 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.